|
|
|
|
LEADER |
03862nam a2200625Ia 4500 |
001 |
10.1111-cid.12553 |
008 |
220706s2018 CNT 000 0 und d |
020 |
|
|
|a 15230899 (ISSN)
|
245 |
1 |
0 |
|a Lnc-NTF3-5 promotes osteogenic differentiation of maxillary sinus membrane stem cells via sponging miR-93-3p
|
260 |
|
0 |
|b Blackwell Publishing Ltd
|c 2018
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1111/cid.12553
|
520 |
3 |
|
|a Background: The function and the mechanism of long non-coding RNAs (lncRNAs) on the osteogenic differentiation of maxillary sinus membrane stem cells (MSMSCs) remain largely unknown. Materials and Methods: The expression of lnc-NTF3-5 and Runt-related transcription factor 2 (RUNX2), Osterix (OSX), and Alkaline Phosphatase (ALP) was examined by quantitative real-time PCR (qRT-PCR) in MSMSCs during the process osteogenic differentiation. Then the function of lnc-NTF3-5 was evaluated by loss- and gain-of-function techniques, as well as qRT-PCR, western blot, and Alizarin Red staining. In addition, the microRNAs (miRNAs) sponge potential of lnc-NTF3-5 was assessed through RNA immunoprecipitation, dual luciferase reporter assay, and in vivo ectopic bone formation. Results: Lnc-NTF3-5, RUNX2, OSX, and ALP increased alone with the differentiation. Inhibition of lnc-NTF3-5 decreased the expression of RUNX2, OSX, and ALP both at mRNA and protein levels. Alizarin red staining showed similar trend. In contrast, overexpression of lnc-NTF3-5 presented totally opposite effects. Besides, overexpression of lnc-NTF3-5 could decrease the expression of microRNA-93-3p (miR-93-3p). Enhance miR-93-3p could also inhibit the expression level of lnc-NTF3-5. RNA immunoprecipitation demonstrated that lnc-NTF3-5 is directly bound to miR-93-3p and dual luciferase reporter assay proved that miR-93-3p targets 3′ UTR of RUNX2 to regulate its expression. Ultimately, in vivo bone formation study showed that lnc-NTF3-5 and miR-93-3p inhibitor co-transfection group displayed the strongest bone formation. Conclusions: The novel pathway lnc-NTF3-5/miR-93-3p/RUNX2 could regulate osteogenic differentiation of MSMSCs and might serve as a therapeutic target for bone regeneration in the posterior maxilla. © 2017 The Authors Clinical Implant Dentistry and Related Research Published by Wiley Periodicals, Inc.
|
650 |
0 |
4 |
|a alkaline phosphatase
|
650 |
0 |
4 |
|a Alkaline Phosphatase
|
650 |
0 |
4 |
|a bone development
|
650 |
0 |
4 |
|a cell culture
|
650 |
0 |
4 |
|a cell differentiation
|
650 |
0 |
4 |
|a Cell Differentiation
|
650 |
0 |
4 |
|a Cells, Cultured
|
650 |
0 |
4 |
|a Core Binding Factor Alpha 1 Subunit
|
650 |
0 |
4 |
|a cytology
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a Humans
|
650 |
0 |
4 |
|a long non-coding RNAs
|
650 |
0 |
4 |
|a long untranslated RNA
|
650 |
0 |
4 |
|a maxillary sinus
|
650 |
0 |
4 |
|a Maxillary Sinus
|
650 |
0 |
4 |
|a maxillary sinus membrane stem cells
|
650 |
0 |
4 |
|a Metabolic Networks and Pathways
|
650 |
0 |
4 |
|a metabolism
|
650 |
0 |
4 |
|a microRNA
|
650 |
0 |
4 |
|a microRNAs
|
650 |
0 |
4 |
|a MicroRNAs
|
650 |
0 |
4 |
|a MIRN93 microRNA, human
|
650 |
0 |
4 |
|a multipotent stem cell
|
650 |
0 |
4 |
|a Multipotent Stem Cells
|
650 |
0 |
4 |
|a osteoblast
|
650 |
0 |
4 |
|a Osteoblasts
|
650 |
0 |
4 |
|a Osteogenesis
|
650 |
0 |
4 |
|a osteogenic differentiation
|
650 |
0 |
4 |
|a physiology
|
650 |
0 |
4 |
|a real time polymerase chain reaction
|
650 |
0 |
4 |
|a Real-Time Polymerase Chain Reaction
|
650 |
0 |
4 |
|a RNA, Long Noncoding
|
650 |
0 |
4 |
|a Sp7 protein, human
|
650 |
0 |
4 |
|a Sp7 Transcription Factor
|
650 |
0 |
4 |
|a transcription factor osterix
|
650 |
0 |
4 |
|a transcription factor RUNX2
|
700 |
1 |
|
|a Chen, L.-L.
|e author
|
700 |
1 |
|
|a Chen, S.-L.
|e author
|
700 |
1 |
|
|a Peng, W.
|e author
|
700 |
1 |
|
|a Wang, J.
|e author
|
700 |
1 |
|
|a Weng, J.-Q.
|e author
|
700 |
1 |
|
|a Zhu, S.-X.
|e author
|
773 |
|
|
|t Clinical Implant Dentistry and Related Research
|